1.Erratum: Author correction to "SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade" Acta Pharm Sin B 9 (2019) 304-315.
Mingxia ZHAO ; Wenjie GUO ; Yuanyuan WU ; Chenxi YANG ; Liang ZHONG ; Guoliang DENG ; Yuyu ZHU ; Wen LIU ; Yanhong GU ; Yin LU ; Lingdong KONG ; Xiangbao MENG ; Qiang XU ; Yang SUN
Acta Pharmaceutica Sinica B 2025;15(5):2810-2812
[This corrects the article DOI: 10.1016/j.apsb.2018.08.009.].
2.Mechanism of Guilu erxian glue in the treatment of postmenopausal osteoporosis based on non-targeted metabolomics
Dongdong YU ; Qiang GUO ; Kuizhu CHEN ; Haili GU ; Long QIAO ; Ye QIAO
Journal of China Medical University 2025;54(5):390-395
Objective To explore the biological effects and changes of metabolites of Guilu erxian glue(GLE)in vivo in the pre-vention and treatment of postmenopausal osteoporosis(PMO),based on non-targeted metabolomics.Methods Fifty SD female rats were divided into five groups using the random number table method:sham group,model group(OVX),and low-,medium-,and high-dose GLE(GLE-L,GLE-M and GLE-H)groups,with ten mice in each group.After 1 week of modeling,the drug was given by gavage,and samples were collected 8 weeks later.Bone microstructure was detected by MicroCT,bone metabolism-related indices were analyzed by immunohistochemistry(IHC),and a serum metabolite atlas was constructed using the LC-MS/MS technique to observe the distribution differences of metabolites and related pathways.Results The MicroCT results showed that GLE could increase the percentage of bone trabeculae and restore bone microstructure(P<0.05,GLE-M group vs.OVX group).IHC analysis showed that GLE could increase Runx2 expression in femur(P<0.05,GLE-M group vs.OVX group).There were four co-regulated metabolites in the sham group,GLE-H group,and OVX group,including 3-(3-methoxyphenyl)propionic acid,acetamide,Equol,and 1-oleoacyl-SN-glycerol-3-phosphocholine,which showed high expression in the sham group,low expression in the OVX group,and high expression in the GLE-M group.The KEGG pathway result showed that the main pathways involved between the sham group and OVX group were steroid hormone biosynthesis and cortisol synthesis and secretion.Tryptophan metabolism and phenylalanine metabolism were observed in the GLE group and OVX group.Conclusion GLE may prevent PMO by regulating metabolites in the body.
3.Mechanism of Lactylation in Ischemic Heart Diseases
Peng-Fei WANG ; Feng-Li HU ; Guo-Qiang GU
Chinese Journal of Biochemistry and Molecular Biology 2025;41(5):645-652
Ischemic heart disease(IHD)is one of the major threats to global health,characterized by complex and incompletely elucidated pathogenesis.Recently,with the continuous advancement of epige-netic research,lactylation(Kla),a newly discovered type of protein post-translational modification,has gradually attracted attention.Kla significantly influences the pathophysiological processes and cellular molecular functions of IHD by directly affecting gene transcription,signal transduction,and metabolic pathways.Kla extensively occurs in both histones and non-histone proteins and participates in regulating protein functions involved in various pathological processes.By modulating enzymatic activities and signal transduction pathways,Kla affects multiple processes in cardiomyocytes,including energy metabolism,inflammatory response,angiogenesis,lipid metabolic disorders,apoptosis,fibrosis,and myocardial re-pair.Although current studies on specific mechanisms and therapeutic targets of Kla in IHD remain limit-ed,its potential therapeutic value cannot be overlooked.This review summarizes the mechanisms and re-search progress of Kla in critical pathological stages of IHD,such as myocardial infarction,myocardial is-chemia-reperfusion injury,heart failure,and cardiac hypertrophy.Furthermore,we discuss the potential therapeutic targets and application prospects of Kla,aiming to provide insights and directions for identif-ying effective intervention strategies and opening new avenues for the prevention and treatment of IHD.
4.Mechanism of Guilu erxian glue in the treatment of postmenopausal osteoporosis based on non-targeted metabolomics
Dongdong YU ; Qiang GUO ; Kuizhu CHEN ; Haili GU ; Long QIAO ; Ye QIAO
Journal of China Medical University 2025;54(5):390-395
Objective To explore the biological effects and changes of metabolites of Guilu erxian glue(GLE)in vivo in the pre-vention and treatment of postmenopausal osteoporosis(PMO),based on non-targeted metabolomics.Methods Fifty SD female rats were divided into five groups using the random number table method:sham group,model group(OVX),and low-,medium-,and high-dose GLE(GLE-L,GLE-M and GLE-H)groups,with ten mice in each group.After 1 week of modeling,the drug was given by gavage,and samples were collected 8 weeks later.Bone microstructure was detected by MicroCT,bone metabolism-related indices were analyzed by immunohistochemistry(IHC),and a serum metabolite atlas was constructed using the LC-MS/MS technique to observe the distribution differences of metabolites and related pathways.Results The MicroCT results showed that GLE could increase the percentage of bone trabeculae and restore bone microstructure(P<0.05,GLE-M group vs.OVX group).IHC analysis showed that GLE could increase Runx2 expression in femur(P<0.05,GLE-M group vs.OVX group).There were four co-regulated metabolites in the sham group,GLE-H group,and OVX group,including 3-(3-methoxyphenyl)propionic acid,acetamide,Equol,and 1-oleoacyl-SN-glycerol-3-phosphocholine,which showed high expression in the sham group,low expression in the OVX group,and high expression in the GLE-M group.The KEGG pathway result showed that the main pathways involved between the sham group and OVX group were steroid hormone biosynthesis and cortisol synthesis and secretion.Tryptophan metabolism and phenylalanine metabolism were observed in the GLE group and OVX group.Conclusion GLE may prevent PMO by regulating metabolites in the body.
5.Guideline for Adult Weight Management in China
Weiqing WANG ; Qin WAN ; Jianhua MA ; Guang WANG ; Yufan WANG ; Guixia WANG ; Yongquan SHI ; Tingjun YE ; Xiaoguang SHI ; Jian KUANG ; Bo FENG ; Xiuyan FENG ; Guang NING ; Yiming MU ; Hongyu KUANG ; Xiaoping XING ; Chunli PIAO ; Xingbo CHENG ; Zhifeng CHENG ; Yufang BI ; Yan BI ; Wenshan LYU ; Dalong ZHU ; Cuiyan ZHU ; Wei ZHU ; Fei HUA ; Fei XIANG ; Shuang YAN ; Zilin SUN ; Yadong SUN ; Liqin SUN ; Luying SUN ; Li YAN ; Yanbing LI ; Hong LI ; Shu LI ; Ling LI ; Yiming LI ; Chenzhong LI ; Hua YANG ; Jinkui YANG ; Ling YANG ; Ying YANG ; Tao YANG ; Xiao YANG ; Xinhua XIAO ; Dan WU ; Jinsong KUANG ; Lanjie HE ; Wei GU ; Jie SHEN ; Yongfeng SONG ; Qiao ZHANG ; Hong ZHANG ; Yuwei ZHANG ; Junqing ZHANG ; Xianfeng ZHANG ; Miao ZHANG ; Yifei ZHANG ; Yingli LU ; Hong CHEN ; Li CHEN ; Bing CHEN ; Shihong CHEN ; Guiyan CHEN ; Haibing CHEN ; Lei CHEN ; Yanyan CHEN ; Genben CHEN ; Yikun ZHOU ; Xianghai ZHOU ; Qiang ZHOU ; Jiaqiang ZHOU ; Hongting ZHENG ; Zhongyan SHAN ; Jiajun ZHAO ; Dong ZHAO ; Ji HU ; Jiang HU ; Xinguo HOU ; Bimin SHI ; Tianpei HONG ; Mingxia YUAN ; Weibo XIA ; Xuejiang GU ; Yong XU ; Shuguang PANG ; Tianshu GAO ; Zuhua GAO ; Xiaohui GUO ; Hongyi CAO ; Mingfeng CAO ; Xiaopei CAO ; Jing MA ; Bin LU ; Zhen LIANG ; Jun LIANG ; Min LONG ; Yongde PENG ; Jin LU ; Hongyun LU ; Yan LU ; Chunping ZENG ; Binhong WEN ; Xueyong LOU ; Qingbo GUAN ; Lin LIAO ; Xin LIAO ; Ping XIONG ; Yaoming XUE
Chinese Journal of Endocrinology and Metabolism 2025;41(11):891-907
Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.
6.Mechanism of Lactylation in Ischemic Heart Diseases
Peng-Fei WANG ; Feng-Li HU ; Guo-Qiang GU
Chinese Journal of Biochemistry and Molecular Biology 2025;41(5):645-652
Ischemic heart disease(IHD)is one of the major threats to global health,characterized by complex and incompletely elucidated pathogenesis.Recently,with the continuous advancement of epige-netic research,lactylation(Kla),a newly discovered type of protein post-translational modification,has gradually attracted attention.Kla significantly influences the pathophysiological processes and cellular molecular functions of IHD by directly affecting gene transcription,signal transduction,and metabolic pathways.Kla extensively occurs in both histones and non-histone proteins and participates in regulating protein functions involved in various pathological processes.By modulating enzymatic activities and signal transduction pathways,Kla affects multiple processes in cardiomyocytes,including energy metabolism,inflammatory response,angiogenesis,lipid metabolic disorders,apoptosis,fibrosis,and myocardial re-pair.Although current studies on specific mechanisms and therapeutic targets of Kla in IHD remain limit-ed,its potential therapeutic value cannot be overlooked.This review summarizes the mechanisms and re-search progress of Kla in critical pathological stages of IHD,such as myocardial infarction,myocardial is-chemia-reperfusion injury,heart failure,and cardiac hypertrophy.Furthermore,we discuss the potential therapeutic targets and application prospects of Kla,aiming to provide insights and directions for identif-ying effective intervention strategies and opening new avenues for the prevention and treatment of IHD.
7.Guideline for Adult Weight Management in China
Weiqing WANG ; Qin WAN ; Jianhua MA ; Guang WANG ; Yufan WANG ; Guixia WANG ; Yongquan SHI ; Tingjun YE ; Xiaoguang SHI ; Jian KUANG ; Bo FENG ; Xiuyan FENG ; Guang NING ; Yiming MU ; Hongyu KUANG ; Xiaoping XING ; Chunli PIAO ; Xingbo CHENG ; Zhifeng CHENG ; Yufang BI ; Yan BI ; Wenshan LYU ; Dalong ZHU ; Cuiyan ZHU ; Wei ZHU ; Fei HUA ; Fei XIANG ; Shuang YAN ; Zilin SUN ; Yadong SUN ; Liqin SUN ; Luying SUN ; Li YAN ; Yanbing LI ; Hong LI ; Shu LI ; Ling LI ; Yiming LI ; Chenzhong LI ; Hua YANG ; Jinkui YANG ; Ling YANG ; Ying YANG ; Tao YANG ; Xiao YANG ; Xinhua XIAO ; Dan WU ; Jinsong KUANG ; Lanjie HE ; Wei GU ; Jie SHEN ; Yongfeng SONG ; Qiao ZHANG ; Hong ZHANG ; Yuwei ZHANG ; Junqing ZHANG ; Xianfeng ZHANG ; Miao ZHANG ; Yifei ZHANG ; Yingli LU ; Hong CHEN ; Li CHEN ; Bing CHEN ; Shihong CHEN ; Guiyan CHEN ; Haibing CHEN ; Lei CHEN ; Yanyan CHEN ; Genben CHEN ; Yikun ZHOU ; Xianghai ZHOU ; Qiang ZHOU ; Jiaqiang ZHOU ; Hongting ZHENG ; Zhongyan SHAN ; Jiajun ZHAO ; Dong ZHAO ; Ji HU ; Jiang HU ; Xinguo HOU ; Bimin SHI ; Tianpei HONG ; Mingxia YUAN ; Weibo XIA ; Xuejiang GU ; Yong XU ; Shuguang PANG ; Tianshu GAO ; Zuhua GAO ; Xiaohui GUO ; Hongyi CAO ; Mingfeng CAO ; Xiaopei CAO ; Jing MA ; Bin LU ; Zhen LIANG ; Jun LIANG ; Min LONG ; Yongde PENG ; Jin LU ; Hongyun LU ; Yan LU ; Chunping ZENG ; Binhong WEN ; Xueyong LOU ; Qingbo GUAN ; Lin LIAO ; Xin LIAO ; Ping XIONG ; Yaoming XUE
Chinese Journal of Endocrinology and Metabolism 2025;41(11):891-907
Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.
8.The Role and Significance of Caveolin-1 Ubiquitination in Different Diseases
Feng-Li HU ; Peng-Fei WANG ; Guo-Qiang GU
Chinese Journal of Biochemistry and Molecular Biology 2024;40(12):1683-1690
Caveolin-1 (Cav-1) is the main component of caveolin,which can participate in physiological processes such as endocytosis,lipid transport and signal transduction.In recent years,more and more studies have found that the ubiquitination modification of Cav-1 can not only affect the level of Cav-1 it-self,but also cause conformational changes of interacting molecules by changing the protein structure,and then play various roles in different diseases.Cav-1 contains 12 lysine residues,of which 6 lysine res-idues in the N-terminal domain (5/26/30/39/47/57) are essential for the ubiquitination of Cav-1.The types and sites of ubiquitination of Cav-1 are different in diseases,and ubiquitination can be degraded by the ubiquitin-proteasome system and lysosomal pathway.In this paper,we reviewed the relevant studies of Cav-1 ubiquitination in respiratory,digestive,neurological,endocrine,mammary reproduction and other systemic diseases,and found that Cav-1 ubiquitination mainly involves tumor,inflammation,meta-bolic diseases and other disease processes.By reviewing the role of Cav-1 ubiquitination in different dis-ease models and cells,it is hoped to deepen the understanding of the physiological and pathophysiological significance of Cav-1 ubiquitination,and provide directions for possible future interventions.
9.The Role and Significance of Caveolin-1 Ubiquitination in Different Diseases
Feng-Li HU ; Peng-Fei WANG ; Guo-Qiang GU
Chinese Journal of Biochemistry and Molecular Biology 2024;40(12):1683-1690
Caveolin-1 (Cav-1) is the main component of caveolin,which can participate in physiological processes such as endocytosis,lipid transport and signal transduction.In recent years,more and more studies have found that the ubiquitination modification of Cav-1 can not only affect the level of Cav-1 it-self,but also cause conformational changes of interacting molecules by changing the protein structure,and then play various roles in different diseases.Cav-1 contains 12 lysine residues,of which 6 lysine res-idues in the N-terminal domain (5/26/30/39/47/57) are essential for the ubiquitination of Cav-1.The types and sites of ubiquitination of Cav-1 are different in diseases,and ubiquitination can be degraded by the ubiquitin-proteasome system and lysosomal pathway.In this paper,we reviewed the relevant studies of Cav-1 ubiquitination in respiratory,digestive,neurological,endocrine,mammary reproduction and other systemic diseases,and found that Cav-1 ubiquitination mainly involves tumor,inflammation,meta-bolic diseases and other disease processes.By reviewing the role of Cav-1 ubiquitination in different dis-ease models and cells,it is hoped to deepen the understanding of the physiological and pathophysiological significance of Cav-1 ubiquitination,and provide directions for possible future interventions.
10.Analysis of the causes of long-standing pelvic anterior sacral space infection and discussion of management techniques.
Gang Cheng WANG ; Hong Le LI ; Yang LIU ; Xiang Hao GU ; Rui Xia LIU ; Rui FENG ; You Cai WANG ; Ying Jun LIU ; Guo Qiang ZHANG ; Zhi ZHANG ; Hong Li WANG ; Fang WANG ; Yan ZHANG
Chinese Journal of Oncology 2023;45(3):273-278
Objective: To investigate the causes and management of long-term persistent pelvic presacral space infection. Methods: Clinical data of 10 patients with persistent presacral infection admitted to the Cancer Hospital of Zhengzhou University from October 2015 to October 2020 were collected. Different surgical approaches were used to treat the presacral infection according to the patients' initial surgical procedures. Results: Among the 10 patients, there were 2 cases of presacral recurrent infection due to rectal leak after radiotherapy for cervical cancer, 3 cases of presacral recurrent infection due to rectal leak after radiotherapy for rectal cancer Dixons, and 5 cases of presacral recurrent infection of sinus tract after adjuvant radiotherapy for rectal cancer Miles. Of the 5 patients with leaky bowel, 4 had complete resection of the ruptured nonfunctional bowel and complete debridement of the presacral infection using an anterior transverse sacral incision with a large tipped omentum filling the presacral space; 1 had continuous drainage of the anal canal and complete debridement of the presacral infection using an anterior transverse sacral incision. 5 post-Miles patients all had debridement of the presacral infection using an anterior transverse sacral incision combined with an abdominal incision. The nine patients with healed presacral infection recovered from surgery in 26 to 210 days, with a median time of 55 days. Conclusions: Anterior sacral infections in patients with leaky gut are caused by residual bowel secretion of intestinal fluid into the anterior sacral space, and in post-Miles patients by residual anterior sacral foreign bodies. An anterior sacral caudal transverse arc incision combined with an abdominal incision is an effective surgical approach for complete debridement of anterior sacral recalcitrant infections.
Humans
;
Reinfection
;
Rectum/surgery*
;
Rectal Neoplasms/surgery*
;
Drainage
;
Anal Canal/surgery*
;
Pelvic Infection

Result Analysis
Print
Save
E-mail